Cite

HARVARD Citation

    Adachi, K. et al. (n.d.). Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy. Cancer science. 106 (8), pp. 945-950. [Online]. 
  
Back to record